Goldman Sachs Group Inc Clear Point Neuro, Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 257,871 shares of CLPT stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
257,871
Previous 257,871
-0.0%
Holding current value
$3.35 Million
Previous $3.07 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
8.14MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.28MShares$16.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$9.63 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$6.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.76 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$4.3 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $318M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...